Bromantane — the endurance molecule that wakes the body's own dopamine machinery

Bromantane is an actoprotector: a class defined as preparations that enhance the body's stability against physical loads without increasing oxygen consumption or heat production — synthetic adaptogens of non-exhaustive action. Where classic psychostimulants spend the system's reserves, bromantane was built in 1980s Moscow to raise the ceiling: it upregulates expression of tyrosine hydroxylase and DOPA-decarboxylase, the genes that run de novo dopamine synthesis. The human evidence — two Russian clinical trials in asthenia and neurasthenia — is mapped here honestly, tier by tier, alongside the animal and review-level findings. It is an approved prescription medicine in Russia (Ladasten) and an unapproved research compound everywhere else.

What is bromantane?
Bromantane (ADK-709, trade name Ladasten) is an actoprotector — a synthetic adaptogen — developed in Russia. Chemically it is an adamantane-derived secondary amine that supports endurance and anti-fatigue capacity by upregulating tyrosine hydroxylase, the body's own dopamine-synthesis enzyme, rather than by forced stimulation.

Is bromantane a stimulant?
Not in the classic sense. Actoprotectors are agents of non-exhaustive action: bromantane raises dopamine synthesis and release in animal and microdialysis studies, but monoamine reuptake inhibition appears only at concentrations far above clinical relevance, and the Russian clinical trials report no hyperstimulation and no withdrawal after discontinuation.

Is bromantane approved anywhere?
Yes — in Russia it is an approved prescription medicine (Ladasten, 50 mg tablets) for asthenic disorders. It is not FDA-approved and holds no EU or UK marketing authorisation; outside Russia it circulates as a research compound. It has also been prohibited in sport since 1997.

What are peptides?
Peptides are molecules made from two or more amino-acid residues joined by peptide bonds. In everyday biomedical use, the term usually refers to amino-acid chains smaller than proteins, although the exact size boundary is not absolute. Their biological activity depends on sequence, structure and chemical modifications rather than on the word “peptide” alone. — sources: IUPAC Gold Book — peptides, NCBI MeSH — Peptides, NCBI/NCI — peptide definition

How do peptides work in the body?
Many endogenous peptides act as signalling molecules. They bind to receptors, enzymes, membranes or other molecular partners and change cellular behaviour such as hormone release, metabolism, inflammation, growth or tissue signalling. Different peptides can have completely different targets, so “peptides” should never be treated as one biological effect. — sources: Nature Reviews Drug Discovery — Trends in peptide drug discovery, AAMC — 10 questions to ask your doctor about peptides, Tufts Medicine — Peptides explained

What is the difference between peptides and proteins?
Both peptides and proteins are built from amino acids. Peptides are generally shorter chains, while proteins are usually longer and more likely to adopt complex three-dimensional structures. The boundary is conventional rather than absolute, so sequence length alone does not fully determine whether a molecule is called a peptide or protein. — sources: NCBI MeSH — Peptides, Nature Reviews Drug Discovery — Trends in peptide drug discovery

Are peptides steroids?
No. Peptides are amino-acid chains linked by peptide bonds, whereas steroids are molecules built around a characteristic four-ring carbon framework. Some peptides and some steroids can influence overlapping physiological systems, which is why they are sometimes discussed together, but chemically they are very different classes of molecule. — sources: IUPAC Gold Book — peptides, Harvard Health — Peptides: benefits and safety concerns

Are peptides hormones?
Some peptides are hormones, but many are not. Insulin, glucagon, oxytocin and many other signalling molecules are peptide hormones, while other peptides function as neurotransmitters, growth factors, antimicrobial molecules, research probes or synthetic drug candidates. “Peptide” describes chemistry; “hormone” describes biological function. — sources: Nature Reviews Drug Discovery — Trends in peptide drug discovery, AAMC — 10 questions to ask your doctor about peptides

Are peptides the same as amino acids?
No. Amino acids are the individual molecular building blocks. Peptides are formed when two or more amino-acid residues are joined, typically through peptide bonds. A peptide’s properties emerge from the sequence, length, charge, conformation and modifications of its component residues. — sources: IUPAC Gold Book — peptides, NCBI MeSH — Peptides

What is a peptide bond?
A peptide bond is the amide linkage that connects the carbonyl carbon of one amino-acid residue to the nitrogen of another. Repeating peptide bonds create the backbone of peptide chains. The sequence and side chains attached to that backbone determine much of a peptide’s chemistry and biological recognition. — sources: IUPAC Gold Book — peptides

How many amino acids are in a peptide?
There is no universally rigid cutoff. Peptides contain at least two amino-acid residues; terms such as oligopeptide, polypeptide and protein overlap, and different fields use somewhat different length conventions. It is better to state the actual sequence length than rely on a single arbitrary peptide/protein boundary. — sources: NCBI MeSH — Peptides, IUPAC Gold Book — peptides

Are peptides natural or synthetic?
Both. Living organisms produce many peptides naturally, while laboratories can synthesize identical sequences, analogues or entirely designed sequences. Synthetic chemistry also allows non-natural amino acids, cyclization, lipidation and other modifications that can alter stability, potency or pharmacokinetics. — sources: Nature Reviews Drug Discovery — Trends in peptide drug discovery, PubMed — Fmoc Solid-Phase Peptide Synthesis

Why can two peptides have completely different effects?
A change in amino-acid sequence can alter charge, shape, receptor affinity, stability and cellular distribution. Even closely related peptides can therefore engage different targets or behave differently in solution and in vivo. Sequence and structure, not the generic label “peptide,” determine function. — sources: Nature Reviews Drug Discovery — Trends in peptide drug discovery, PubMed — Factors affecting peptide aggregation

Does bromantane cause dependence or withdrawal?
The available evidence says no: the placebo-controlled neurasthenia trial recorded no withdrawal syndrome after discontinuation, and chronic animal administration produced neither dependence nor tolerance. Nearly all of these data are Russian; no Western regulatory-grade safety database exists.